PLAUR and prostate carcinoma: Wang et al. designed for the first time uPAR-targeting nanoparticles for prostate cancer cells; in this study, a GFD-derived peptide inserted into a liposome membrane was used to deliver plasmid DNA to uPAR-expressing cancer cells [147].